| 000 | 02482nam a2200385 i 4500 | ||
|---|---|---|---|
| 999 |
_c8659 _d8659 |
||
| 001 | 29033031 | ||
| 005 | 20170508131846.0 | ||
| 008 | 931007s1993 enk b 001 0 eng d | ||
| 010 | _agb93-19923 | ||
| 020 | _a012274120X (alk. paper) | ||
| 020 | _a9780122741203 | ||
| 020 | _a9789381269701 (hbk.) | ||
| 040 | _erda | ||
| 082 | 0 | 4 |
_222 _a615.7 _bM. |
| 245 | 0 | 0 |
_aMedicinal chemistry : _bthe role of organic chemistry in drug research / _cedited by C.R. Ganellin and S.M. Roberts. |
| 250 | _asecond edition | ||
| 264 | 1 |
_aLondon : _bAcademic Press limited, _c[1993] |
|
| 264 | 4 | _cc1993. | |
| 300 |
_axv, 302 pages : _bcharts, illustartions (some color) ; _c25 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _a1.Introduction to receptors and action of drugs -- 2.Structure and catalytic properties of enzymes -- 3. Receptor pharmacology -- 4. Drug access and prodrugs -- 5. Qsar and the role of computers in drug design -- 6.The current status and future impact of molecular biology in drug discovery -- 7.General approaches to discovering new drugs: An historical perspective -- 8. Discovery and development of cromakalim and related potassium channel activators -- 9. Angiotensin-converting enzyme (ACE) inhibitors and the design of cilazapril -- 10. Beta blockers -- 11. Salbutamol: a selective B2 - stimulant bronchodilator -- 12. Discovery of cimetidine, ranitidine and other H2-receptor histamine antagonists -- 13. Fluconazole, an orally active antifungal agent -- 14. Clavulanic acid and related compounds: inhibitors of B-lactamase enzymes | |
| 520 | _aThis book is aimed primarily at final year organic/medicinal chemists considering a research career in drug development. Recent exciting progress is reported in the chapters on individual drugs by their developers for the second edition of medicinal chemistry. In addition, this volume benefits from new chapters dealing with structure-activity relationships, the role of molecular biology in drug discovery, and drug access and prodrugs. | ||
| 650 | 2 | _aChemistry, Pharmaceutical. | |
| 650 | 2 |
_aPharmaceutical Preparations _xhistory. |
|
| 650 | 2 | _aPharmacology. | |
| 650 | 0 | _aPharmaceutical chemistry. | |
| 650 | 0 |
_aDrugs _xResearch. |
|
| 653 | 0 | _aSynthesis. | |
| 700 | 1 |
_aGanellin, C. R. _q(C. Robin) _eeditor. |
|
| 700 | 1 | _aRoberts, Stanley M. | |
| 942 |
_cBK _2ddc |
||